Company: SCAG
Filing Date: 2025-01-06
Form Type: 424B3
Source: 0001213900-25-001215
Chunk: 196

Company: Scage Future
Filing Date: 2025-01-06
Form: 424B3
Chunk 196
---
 shares if not purchased in the open market or the nature of the sellers; and (v) the number of Finnovate Ordinary Shares for which Finnovate has received redemption requests. The Sponsor, Finnovate’s directors, officers, advisors, and their affiliates may elect to purchase Finnovate Public Shares prior to the consummation of the Business Combination, which may influence the vote on the Business Combination and reduce the public “float” of Finnovate Ordinary Shares. At any time prior to the Meeting, during a period when they are not then aware of any material nonpublic information regarding Finnovate or its securities, Finnovate’s directors and officers, the Sponsor, Scage International and/or their respective affiliates may purchase Finnovate Public Shares or Public Warrants from investors, or they may enter into transactions with such investors and others to provide them with incentives to acquire Finnovate Ordinary Shares. As of the date of this proxy statement/prospectus, there have been no such discussions and no agreements with respect to such a transaction have been entered into with any such person. If such a transaction were to occur, it is contemplated that, in accordance with the SEC’s Compliance and Disclosure Interpretation 166.01, such persons would agree, among other things, that: (i) the purchase price for the Finnovate Ordinary Shares will not exceed the redemption price; (ii) the persons described above will waive redemption rights, if any, with respect to the Finnovate Public Shares they acquire in such transactions; and (iii) any such Finnovate Ordinary Shares acquired by the persons described above would not vote on the Business Combination Proposal. The purpose of such share purchases and other transactions would be to increase the likelihood that the conditions to the consummation of the Business Combination are satisfied. This may result in the completion of our Business Combination that may not otherwise have been possible. While the exact nature of any such incentives has not been determined as of the date of this proxy statement/prospectus, they might include, without limitation, arrangements to protect such investors or holders against potential loss in value of their shares, including the granting of put options. As of the date of this proxy statement/prospectus, there have been no such discussions and no agreements to such effect have been entered into with any such investor or holder. If such arrangements or agreements are entered into, Finnovate will file a Current Report on Form 8 -Kprior to the Meeting to disclose any arrangements entered into or significant purchases made by any